Zai Lab

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.

CEO

Ying Du

CEOYing Du

Employees

1,869

Employees1,869

Headquarters

Shanghai, Shanghai

HeadquartersShanghai, Shanghai

Founded

2014

Founded2014

Employees

1,869

Employees1,869

ZLAB Key Statistics

Market cap

4.55B

Market cap4.55B

Price-Earnings ratio

-16.57

Price-Earnings ratio-16.57

Dividend yield

—

Dividend yield—

Average volume

1.07M

Average volume1.07M

High today

$43.77

High today$43.77

Low today

$43.77

Low today$43.77

Open price

$40.49

Open price$40.49

Volume

2.24K

Volume2.24K

52 Week high

$43.77

52 Week high$43.77

52 Week low

$16.01

52 Week low$16.01

Analyst ratings

88%

of 16 ratings

Buy

87.5%

Hold

12.5%

Sell

Zai Lab

Why Robinhood?

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. Show more

ZLAB Key Statistics

Analyst ratings

88%

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.